PKK deficiency in B cells prevents lupus development in Sle lupus mice

D. Oleksyn, J. Zhao, A. Vosoughi, J. C. Zhao, R. Misra, A. P. Pentland, D. Ryan, J. Anolik, C. Ritchlin, J. Looney, A. P. Anandarajah, G. Schwartz, L. M. Calvi, M. Georger, C. Mohan, I. Sanz, L. Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can result in damage to multiple organs. It is well documented that B cells play a critical role in the development of the disease. We previously showed that protein kinase C associated kinase (PKK) is required for B1 cell development as well as for the survival of recirculating mature B cells and B-lymphoma cells. Here, we investigated the role of PKK in lupus development in a lupus mouse model. We demonstrate that the conditional deletion of PKK in B cells prevents lupus development in Sle1Sle3 mice. The loss of PKK in Sle mice resulted in the amelioration of multiple classical lupus-associated phenotypes and histologic features of lupus nephritis, including marked reduction in the levels of serum autoantibodies, proteinuria, spleen size, peritoneal B-1 cell population and the number of activated CD4 T cells. In addition, the abundance of autoreactive plasma cells normally seen in Sle lupus mice was also significantly decreased in the PKK-deficient Sle mice. Sle B cells deficient in PKK display defective proliferation responses to BCR and LPS stimulation. Consistently, B cell receptor-mediated NF-κB activation, which is required for the survival of activated B cells, was impaired in the PKK-deficient B cells. Taken together, our work uncovers a critical role of PKK in lupus development and suggests that targeting the PKK-mediated pathway may represent a promising therapeutic strategy for lupus treatment.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalImmunology Letters
Volume185
DOIs
StatePublished - May 1 2017

Fingerprint

B-Lymphocytes
Autoantibodies
Lupus Nephritis
B-Cell Lymphoma
Plasma Cells
Proteinuria
Systemic Lupus Erythematosus
Autoimmune Diseases
Prekallikrein Deficiency
Chronic Disease
Spleen
Cell Count
T-Lymphocytes
Phenotype
Serum
Population
Therapeutics

Keywords

  • BCR
  • Lupus
  • Mouse model
  • PKK

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Oleksyn, D., Zhao, J., Vosoughi, A., Zhao, J. C., Misra, R., Pentland, A. P., ... Chen, L. (2017). PKK deficiency in B cells prevents lupus development in Sle lupus mice. Immunology Letters, 185, 1-11. https://doi.org/10.1016/j.imlet.2017.03.002

PKK deficiency in B cells prevents lupus development in Sle lupus mice. / Oleksyn, D.; Zhao, J.; Vosoughi, A.; Zhao, J. C.; Misra, R.; Pentland, A. P.; Ryan, D.; Anolik, J.; Ritchlin, C.; Looney, J.; Anandarajah, A. P.; Schwartz, G.; Calvi, L. M.; Georger, M.; Mohan, C.; Sanz, I.; Chen, L.

In: Immunology Letters, Vol. 185, 01.05.2017, p. 1-11.

Research output: Contribution to journalArticle

Oleksyn, D, Zhao, J, Vosoughi, A, Zhao, JC, Misra, R, Pentland, AP, Ryan, D, Anolik, J, Ritchlin, C, Looney, J, Anandarajah, AP, Schwartz, G, Calvi, LM, Georger, M, Mohan, C, Sanz, I & Chen, L 2017, 'PKK deficiency in B cells prevents lupus development in Sle lupus mice', Immunology Letters, vol. 185, pp. 1-11. https://doi.org/10.1016/j.imlet.2017.03.002
Oleksyn D, Zhao J, Vosoughi A, Zhao JC, Misra R, Pentland AP et al. PKK deficiency in B cells prevents lupus development in Sle lupus mice. Immunology Letters. 2017 May 1;185:1-11. https://doi.org/10.1016/j.imlet.2017.03.002
Oleksyn, D. ; Zhao, J. ; Vosoughi, A. ; Zhao, J. C. ; Misra, R. ; Pentland, A. P. ; Ryan, D. ; Anolik, J. ; Ritchlin, C. ; Looney, J. ; Anandarajah, A. P. ; Schwartz, G. ; Calvi, L. M. ; Georger, M. ; Mohan, C. ; Sanz, I. ; Chen, L. / PKK deficiency in B cells prevents lupus development in Sle lupus mice. In: Immunology Letters. 2017 ; Vol. 185. pp. 1-11.
@article{0184763eb9314e168b4f34bb76256c4a,
title = "PKK deficiency in B cells prevents lupus development in Sle lupus mice",
abstract = "Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can result in damage to multiple organs. It is well documented that B cells play a critical role in the development of the disease. We previously showed that protein kinase C associated kinase (PKK) is required for B1 cell development as well as for the survival of recirculating mature B cells and B-lymphoma cells. Here, we investigated the role of PKK in lupus development in a lupus mouse model. We demonstrate that the conditional deletion of PKK in B cells prevents lupus development in Sle1Sle3 mice. The loss of PKK in Sle mice resulted in the amelioration of multiple classical lupus-associated phenotypes and histologic features of lupus nephritis, including marked reduction in the levels of serum autoantibodies, proteinuria, spleen size, peritoneal B-1 cell population and the number of activated CD4 T cells. In addition, the abundance of autoreactive plasma cells normally seen in Sle lupus mice was also significantly decreased in the PKK-deficient Sle mice. Sle B cells deficient in PKK display defective proliferation responses to BCR and LPS stimulation. Consistently, B cell receptor-mediated NF-κB activation, which is required for the survival of activated B cells, was impaired in the PKK-deficient B cells. Taken together, our work uncovers a critical role of PKK in lupus development and suggests that targeting the PKK-mediated pathway may represent a promising therapeutic strategy for lupus treatment.",
keywords = "BCR, Lupus, Mouse model, PKK",
author = "D. Oleksyn and J. Zhao and A. Vosoughi and Zhao, {J. C.} and R. Misra and Pentland, {A. P.} and D. Ryan and J. Anolik and C. Ritchlin and J. Looney and Anandarajah, {A. P.} and G. Schwartz and Calvi, {L. M.} and M. Georger and C. Mohan and I. Sanz and L. Chen",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.imlet.2017.03.002",
language = "English (US)",
volume = "185",
pages = "1--11",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",

}

TY - JOUR

T1 - PKK deficiency in B cells prevents lupus development in Sle lupus mice

AU - Oleksyn, D.

AU - Zhao, J.

AU - Vosoughi, A.

AU - Zhao, J. C.

AU - Misra, R.

AU - Pentland, A. P.

AU - Ryan, D.

AU - Anolik, J.

AU - Ritchlin, C.

AU - Looney, J.

AU - Anandarajah, A. P.

AU - Schwartz, G.

AU - Calvi, L. M.

AU - Georger, M.

AU - Mohan, C.

AU - Sanz, I.

AU - Chen, L.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can result in damage to multiple organs. It is well documented that B cells play a critical role in the development of the disease. We previously showed that protein kinase C associated kinase (PKK) is required for B1 cell development as well as for the survival of recirculating mature B cells and B-lymphoma cells. Here, we investigated the role of PKK in lupus development in a lupus mouse model. We demonstrate that the conditional deletion of PKK in B cells prevents lupus development in Sle1Sle3 mice. The loss of PKK in Sle mice resulted in the amelioration of multiple classical lupus-associated phenotypes and histologic features of lupus nephritis, including marked reduction in the levels of serum autoantibodies, proteinuria, spleen size, peritoneal B-1 cell population and the number of activated CD4 T cells. In addition, the abundance of autoreactive plasma cells normally seen in Sle lupus mice was also significantly decreased in the PKK-deficient Sle mice. Sle B cells deficient in PKK display defective proliferation responses to BCR and LPS stimulation. Consistently, B cell receptor-mediated NF-κB activation, which is required for the survival of activated B cells, was impaired in the PKK-deficient B cells. Taken together, our work uncovers a critical role of PKK in lupus development and suggests that targeting the PKK-mediated pathway may represent a promising therapeutic strategy for lupus treatment.

AB - Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can result in damage to multiple organs. It is well documented that B cells play a critical role in the development of the disease. We previously showed that protein kinase C associated kinase (PKK) is required for B1 cell development as well as for the survival of recirculating mature B cells and B-lymphoma cells. Here, we investigated the role of PKK in lupus development in a lupus mouse model. We demonstrate that the conditional deletion of PKK in B cells prevents lupus development in Sle1Sle3 mice. The loss of PKK in Sle mice resulted in the amelioration of multiple classical lupus-associated phenotypes and histologic features of lupus nephritis, including marked reduction in the levels of serum autoantibodies, proteinuria, spleen size, peritoneal B-1 cell population and the number of activated CD4 T cells. In addition, the abundance of autoreactive plasma cells normally seen in Sle lupus mice was also significantly decreased in the PKK-deficient Sle mice. Sle B cells deficient in PKK display defective proliferation responses to BCR and LPS stimulation. Consistently, B cell receptor-mediated NF-κB activation, which is required for the survival of activated B cells, was impaired in the PKK-deficient B cells. Taken together, our work uncovers a critical role of PKK in lupus development and suggests that targeting the PKK-mediated pathway may represent a promising therapeutic strategy for lupus treatment.

KW - BCR

KW - Lupus

KW - Mouse model

KW - PKK

UR - http://www.scopus.com/inward/record.url?scp=85014866378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014866378&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2017.03.002

DO - 10.1016/j.imlet.2017.03.002

M3 - Article

VL - 185

SP - 1

EP - 11

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

ER -